Chest ACCP Education Calendar
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text Free
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Pauwels, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pauwels, R. A.
(Chest. 2000;117:20S-22S.)
© 2000 American College of Chest Physicians

National and International Guidelines for COPD*

The Need for Evidence

Romain A. Pauwels, MD, PhD, FCCP

* From the Department of Respiratory Diseases, University Hospital, Gent, Belgium.

Correspondence to: Romain Pauwels, MD, PhD, FCCP, Department of Respiratory Diseases, University Hospital, De Pintelaan 185, B-9000, Gent, Belgium; e-mail: romain.pauwels{at}rug.ac.be

The introduction of guidelines for the management of asthma has led to standardization of management and better care of patients with the condition. Many national and international respiratory societies have developed guidelines for COPD. The World Health Organization and the National Heart, Lung, and Blood Institute are jointly developing guidelines that will present evidence-based recommendations for the management of COPD. The guidelines will discuss the definition, epidemiology, natural history, risk factors, pathology, and diagnosis of COPD. There will be guidance on the management of chronic disease and acute exacerbations, education, prevention, and socioeconomics.

Key Words: COPD • evidence-based medicine • management guidelines




This article has been cited by other articles:


Home page
 Eur Respir JHome page
M.L. Ayers, R. Mejia, J. Ward, T. Lentine, and D.A. Mahler
Effectiveness of salmeterol versus ipratropium bromide on exertional dyspnoea in COPD
Eur. Respir. J., June 1, 2001; 17(6): 1132 - 1137.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
A. D. D'Urzo, M. C. De Salvo, A. Ramirez-Rivera, J. Almeida, L. Sichletidis, G. Rapatz, and J. Kottakis
In Patients With COPD, Treatment With a Combination of Formoterol and Ipratropium Is More Effective Than a Combination of Salbutamol and Ipratropium : A 3-Week, Randomized, Double-Blind, Within-Patient, Multicenter Study
Chest, May 1, 2001; 119(5): 1347 - 1356.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
P. M. A. Calverley
The Future for Tiotropium
Chest, February 1, 2000; 117(2_suppl): 67S - 69S.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American College of Chest Physicians.